Paxlovid Rebound Incidence Low, Study Suggests

(MedPage Today) -- Only a very small number of high-risk patients with COVID-19 experienced "rebound symptoms" after being treated with nirmatrelvir/ritonavir (Paxlovid), a retrospective study found.
Among nearly 500 patients, 93% of whom were...